Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stefania Morganti, M.D.

Concepts (109)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms182024210121.170 Why?
High-Throughput Nucleotide Sequencing2201936390.530 Why?
Pharmacogenetics120196750.480 Why?
Receptor, erbB-29202425570.410 Why?
Drug Resistance, Neoplasm3202453050.350 Why?
Neoplasms82024221640.330 Why?
BRCA2 Protein220248050.310 Why?
Data Interpretation, Statistical1201826910.310 Why?
BRCA1 Protein2202411550.280 Why?
Antineoplastic Agents72024136370.260 Why?
Immunotherapy6202446500.240 Why?
Immunoconjugates220239540.230 Why?
Receptors, Estrogen2202322080.230 Why?
Epirubicin12022810.210 Why?
Genomics1201858200.210 Why?
Clinical Trials, Phase III as Topic320208570.190 Why?
Receptors, Fibroblast Growth Factor120211910.180 Why?
Phthalazines120233830.180 Why?
Female2320243925810.160 Why?
Receptors, Progesterone1202311290.160 Why?
Fluorouracil1202216390.150 Why?
Protein Kinase Inhibitors3202456650.140 Why?
Bone Resorption120217230.140 Why?
Prognosis52024296200.140 Why?
Cyclophosphamide1202222180.140 Why?
Humans3120247614230.140 Why?
Ketones120171840.130 Why?
Furans120172010.130 Why?
Proto-Oncogene Proteins c-akt1202424550.130 Why?
Fibroblast Growth Factors120218670.130 Why?
Antineoplastic Combined Chemotherapy Protocols52024117400.130 Why?
Disease-Free Survival2202268140.120 Why?
Lymphocytes, Tumor-Infiltrating1202110900.120 Why?
Germ-Line Mutation1202318580.120 Why?
Clinical Trials, Phase II as Topic320246290.120 Why?
Neoplasms, Second Primary1202210510.120 Why?
Neoplasm Recurrence, Local2202392770.120 Why?
Carcinoma, Intraductal, Noninfiltrating120219260.120 Why?
Carcinoma, Ductal, Breast1202110850.120 Why?
Chemotherapy, Adjuvant1202235140.110 Why?
Immunologic Factors1202315880.110 Why?
Diagnostic Tests, Routine120187870.100 Why?
Neoplasm Metastasis5202149120.100 Why?
History, 21st Century1201815670.100 Why?
Carcinoma, Non-Small-Cell Lung2202053020.100 Why?
Tumor Microenvironment2202138740.090 Why?
Clinical Trials, Phase I as Topic220243260.090 Why?
Recurrence1202384690.090 Why?
Adiposity1202118770.090 Why?
History, 20th Century1201827690.090 Why?
Bone Neoplasms1202125290.080 Why?
Randomized Controlled Trials as Topic32020102030.080 Why?
Mutation32024300450.080 Why?
Neoplasm Staging22020111060.080 Why?
Medical Oncology1202023210.080 Why?
Immunohistochemistry12021110730.070 Why?
Prevalence12024157170.070 Why?
Lung Neoplasms22020133370.060 Why?
Case-Control Studies12023221680.060 Why?
Treatment Outcome42024646510.060 Why?
Aged, 80 and over32024589560.060 Why?
Adult620242211480.060 Why?
Risk Assessment22022239900.050 Why?
Body Mass Index12021129510.050 Why?
Research Design1201861780.050 Why?
Neoadjuvant Therapy2202428260.050 Why?
Disease Progression12018135020.050 Why?
Aged620241692350.050 Why?
Middle Aged720242208260.050 Why?
Drug Synergism1202417550.040 Why?
Immunotoxins120201750.040 Why?
Organ Specificity1202419670.040 Why?
Molecular Targeted Therapy2202128110.040 Why?
Oxazoles120201990.040 Why?
Young Adult22024592070.040 Why?
Antibodies, Monoclonal3202091790.040 Why?
Prospective Studies12024544150.040 Why?
Cell Death1202416770.040 Why?
Obesity12021129380.040 Why?
Lymphocyte Count120207780.040 Why?
Xenograft Model Antitumor Assays1202436020.030 Why?
Survival Rate22021127200.030 Why?
Retreatment120175980.030 Why?
Retrospective Studies52024805820.030 Why?
Histone Deacetylase Inhibitors120207740.030 Why?
Drug Therapy, Combination1202463090.030 Why?
Quinazolines1202013710.030 Why?
Drug Discovery1202110510.030 Why?
Breast1202119660.030 Why?
Lymphocytes1202026110.030 Why?
Cancer Vaccines1202010500.030 Why?
Biopsy1202467660.020 Why?
Pyridines1202028750.020 Why?
Cell Line, Tumor12024169790.020 Why?
Quality of Life22021133610.020 Why?
Neutrophils1202037660.020 Why?
Age Factors12024184000.020 Why?
Cell Differentiation12024115260.020 Why?
Kaplan-Meier Estimate1201764790.020 Why?
Cell Proliferation12021104410.020 Why?
Animals320241684410.020 Why?
Gene Expression Regulation, Neoplastic1202185450.020 Why?
Clinical Trials as Topic1202080000.010 Why?
Male320243607360.010 Why?
Algorithms12020140260.010 Why?
Time Factors12021399750.010 Why?
Signal Transduction12021234410.010 Why?
Mice12024815090.010 Why?
Risk Factors12021741670.010 Why?
Morganti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (109)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.